Parathyroid hormone decreased the incorpo- (5), and net accumulation of bone collagen decreases (6). Similarly, PTH inhibits the synthesis of collagen in osteoblast-like cells derived from 2-to 3-day mouse calvaria by sequential enzymatic digestion (7). The molecular mechanism by which PTH alters collagen synthesis in these bone cultures is unknown. Because procollagen mRNA levels appears to be the primary regulatory site for changes in collagen synthesis in embryonic chicken calvaria (8), a likely hypothesis is that PTH regulates collagen synthesis in fetal rat bone by altering the level of procollagen mRNA. On the other hand, PTH is a potent stimulator of bone resorption (9, 10) and could have a posttranslational effect on collagen levels by enhancing the degradation of newly synthesized collagen.
cultured 21-day fetal rat calvaria but had little effect on the labeling of noncollagen protein. After 24 hr of culture, there was a 50% reduction in collagen synthesis and a 40% decrease in the level of functional procollagen mRNA as measured in a reticulocyte lysate translation assay. The effect of parathyroid hormone on both parameters was detectable after 6hrof treatment. In these cultures, there was also a substantial degradation or release of newly synthesized collagen from the calvaria, but parathyroid hormone had little effect on the release of collagen into the medium. These results suggest that parathyroid hormone inhibits collagen synthesis primarily by decreasing the steady-state level of procollagen mRNA. When bone is treated with parathyroid hormone (PTH), there is a substantial decline in osteoblast function and collagen synthesis (1) (2) (3) . In 21-day fetal rat calvaria maintained in organ culture for hr, PTH at I nM to gM decreases the incorporation of [3H]proline into collagenase-digestible protein (CDP) but has little effect on the labeling of noncollagen protein (NCP) (4) . During this interval, characteristic polygonal osteoblasts are replaced by spindle-shaped cells (5) , and net accumulation of bone collagen decreases (6) . Similarly, PTH inhibits the synthesis of collagen in osteoblast-like cells derived from 2-to 3-day mouse calvaria by sequential enzymatic digestion (7) .
The molecular mechanism by which PTH alters collagen synthesis in these bone cultures is unknown. Because procollagen mRNA levels appears to be the primary regulatory site for changes in collagen synthesis in embryonic chicken calvaria (8) , a likely hypothesis is that PTH regulates collagen synthesis in fetal rat bone by altering the level of procollagen mRNA. On the other hand, PTH is a potent stimulator of bone resorption (9, 10) and could have a posttranslational effect on collagen levels by enhancing the degradation of newly synthesized collagen.
One objective of the present study was to determine whether the ability of PTH to inhibit collagen synthesis in cultures of fetal rat calvaria could be correlated with alterations in the level of functional procollagen mRNA. Another was to assess the effect of PTH on the release of newly synthesized collagen from these calvaria into the culture medium. Our results demonstrate that PTH decreases both collagen synthesis and the bone level of procollagen mRNA but has only a small effect on the release of collagen into the medium, indicating that PTH regulates collagen synthesis primarily through an effect on procollagen mRNA levels.
MATERIALS AND METHODS Culture Method. The frontal and parietal bones were removed from 21-day fetal rats (Sprague-Dawley; Charles River Breeding Laboratories) and split along the sagittal suture. Half calvaria were cultured at 370C under a humidified atmosphere of 5% C02/95% air in 25-ml erlenmeyer flasks containing 2 ml of modified BGJ medium (11) supplemented with bovine serum albumin at 1 mg/ml or with 5% human serum that had been heated at 56°C for 30 min. The concentration of unlabeled proline in the medium was 1 mM except where indicated. Half calvaria were cultured for 24 (12) and was linear for at least 120 min in both control and PTH-treated calvaria (Fig. 1) . The percentage collagen synthesized by the bones was corrected for the relative abundance of proline residues in collagen compared to NCP (13 (8, 15) . Calvaria were cultured as described but were not given [3H]proline. After culture, these calvaria were frozen in liquid N2 and stored at -800C. Eight to 10 half calvaria were disrupted with a Polytron (Brinkman) and then homogenized by using several strokes of a tight-fitting Dounce homogenizer in 5 ml of SET buffer containing proteinase K (E. Merck Darmstadt, Germany) at 50Mg/ml. After 1 hr at 370C the homogenate was extracted with 8 ml of phenol (saturated with 0.5 M Tris-HCI at pH 7.5)/chloroform, 1:1 (vol/vol). The aqueous phase was adjusted to 0.1 M in NaCl, and total nucleic acids were precipitated overnight by addition of 2 vol of absolute ethanol. The precipitate was collected by centrifugation at 19,000 X g for 10 min, washed once with 66% ethanol/0.1 M NaCl, and lyophilized. Total nucleic acids were dissolved in 0.4 ml of 6 M guanidine-HCI at pH 7.0 and heated to 60°C for 5 min. DNA was quantitated by using a fluorometric assay (16) . RNA was separated from DNA by precipitation with 0.2 ml of absolute ethanol after overnight storage at -200C. The precipitate was collected by centrifugation at 19,000 X g for 10 min, washed once with 4 M guanidine-HCI/33% ethanol and twice with 60% ethanol/0.1 M NaCl, drained, and lyophilized. The residue (total RNA) was redissolved in 0.1-0.15 ml of 10 mM Hepes (pH 7.4), heated at 60°C for 5 Translation of total RNA was performed by using a micrococcal nuclease-treated reticulocyte lysate, filtered on Sephadex G-50, prepared in this laboratory as described (15) . The 5SO-I reaction mixture contained 10 Ml of the treated lysate, 5- (15) was added and the resulting precipitate was collected by centrifugation through a sucrose/detergent solution as described (17) .
Background radioactivity nonspecifically trapped by the immunoprecipitate was estimated by determining the cpm in an albumin-antialbumin precipitate of size similar to the antiprocollagen precipitate. Radioactivity in the immunoprecipitate was solubilized in TS-1 (Research Products International, Elk Grove Village, IL) and assayed in 4 ml of toluene scintillation fluid. Procollagen mRNA is expressed as cpm of immunoprecipitable collagen translated per Mg of total RNA per ml.
The products made during in vitro translation were analyzed on 5% acrylamide slab gels (18) and identified by fluorography (19 RNA in the reticulocyte lysate (Fig. 2) . Over the range 5-20 ,ug of total RNA per ml, the curve for translation of RNA extracted either from control or PTH-treated calvaria was linear. Furthermore, RNA extracted from PTH-treated calvaria had less activity than did RNA extracted from control calvaria. Analysis of the translation products on 5% acrylamide slab gels (Fig. 3) indicated that the immunoprecipitate contained procollagen a, and procollagen a2 chains plus smaller products. All translation products were collagenase-sensitive. The intensity of the bands representing procollagen synthesized by the calvaria in organ culture or in the cell-free translation system was decreased by PTH. Results of a typical experiment in which calvaria were analyzed for protein synthesis and procollagen mRNA Table 2 . After 24 hr of exposure to PTH, bone procollagen mRNA was decreased by nearly 40% and the ability to incorporate [3H]proline into CDP and the percentage collagen being synthesized by the calvaria were decreased about 50%. In five separate experiments, a 24-hr incubation with PTH consistently decreased the steady-state level of procollagen mRNA by 50 E 6% (SEM) and the labeling of CDP by 58 ± 3% (SEM), demonstrating that the decline in collagen synthesis is associated with a decrease in the level of functional procollagen mRNA. PTH specifically decreased functional procollagen mRNA because total protein synthesis in the reticulocyte lysate was equal with RNA extracted from control or PTH-treated calvaria.
To determine the time course of action of PTH in inhibiting collagen synthesis and procollagen mRNA accumulation, calvaria were put into cultures supplemented with PTH at various times before the end of the 24-hr incubation period. Procollagen mRNA levels were unaffected when calvaria were incubated with PTH for 3 hr. Bone procollagen mRNA steadily decreased after longer exposure to the hormone and was 60% of the control at 24 hr. Similarly, the labeling of CDP declined in the presence of PTH (Fig. 4) . However, at all time points examined after 3 hr, the decrease in the labeling of CDP was greater than the decrease in procollagen mRNA levels.
One explanation for the observation that PTH inhibits collagen synthesis to a greater extent than it inhibits procollagen mRNA accumulation is that PTH (2) demonstrated that acute administration of parathyroid extract to rats 6-18 hr before sacrifice decreased the incorporation of radioactive proline into collagen of excised bone fragments. In the present studies, the decline in procollagen mRNA and collagen synthesis in vitro occurred over a similar time interval. Johnston and coworkers (3) showed that the labeling of bone collagen in vitro was deBiochemistry: Kream et al. pressed 3-15 hr after administration parathyroid extract in svo but was increased above control at 36-74 hr. A likely explanation for the stimulatory effect of PTH on osteoblast proliferation and collagen synthesis in vivo is that these responses are indirect and are mediated by other hormones or factors. Another explanation is that osteoblast number is increased in response to enhanced bone resorption. * The reduction in procollagen mRNA induced by PTH in fetal rat calvaria could result from an alteration in the rate of transcription of the procollagen genes or a change in the metabolism of procollagen mRNA. In mammary gland organ culture, the increase in accumulation of casein mRNA caused by prolactin (25) can be explained only in part by an increased rate of gene transcription (26) . Rather, the regulation of casein production by prolactin involves a coordinate response at the level of transcription, posttranscription, and other sites. It is possible that a similar pattern of coordinate regulation exists fot the control of collgen synthesis by PTH. Bone organ culture will provide an excellent system for studying the effect of PTH on the synthesis and metabolism of procollagen mRNA. 
